Public Profile

Avedro, Inc.

Avedro, Inc., a pioneering name in the ophthalmic industry, is headquartered in the United States and operates extensively across major regions, including North America and Europe. Founded in 2000, Avedro has made significant strides in the field of corneal cross-linking, a revolutionary treatment for keratoconus and other corneal disorders. The company’s flagship products, including the KXL System and the proprietary riboflavin solutions, are distinguished by their innovative approach to strengthening corneal tissue, thereby enhancing patient outcomes. Avedro's commitment to advancing eye care has positioned it as a leader in the market, with notable achievements such as FDA approvals and a growing global presence. Through its cutting-edge technology and dedication to research, Avedro continues to shape the future of ophthalmology.

DitchCarbon Score

How does Avedro, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Avedro, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Avedro, Inc.'s reported carbon emissions

Avedro, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for recent years. As such, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of emissions data, it is important to note that Avedro has not outlined any specific reduction targets or commitments to climate initiatives. This lack of publicly stated climate commitments may reflect a broader industry context where many companies are increasingly focusing on sustainability and carbon reduction strategies. As the conversation around climate change intensifies, Avedro may consider establishing measurable targets and initiatives to align with industry standards and expectations for corporate responsibility in reducing carbon emissions.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Avedro, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Avedro, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Avedro, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

SOOFT Italia S.p.a.

IT
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers